Pan-cancer analysis reveals NAA50 as a cancer prognosis and immune infiltration-related biomarker.

Fang, Tao; Wang, Dingxin; Li, Rongyang; Yu, Wenhao; Tian, Hui

Fang, Tao; Wang, Dingxin; Li, Rongyang; Yu, Wenhao; Tian, Hui.

Afiliação

Fang T; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Wang D; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Li R; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Yu W; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
Tian H; Department of Thoracic Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Front Genet ; 13: 1035337, 2022.

Article em En | MEDLINE | ID: mdl-36568377

Palavras-chave

N-alpha-acetyltransferase 50 (NAA50); biomarker; immune infiltration; lung adenocarcinoma (LUAD); pan-cancer analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Genet Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google